Cite
APA Citation
Calvaruso, V., Petta, S., Ferraro, D., La Mantia, C., Reina, G., Zarcone, A., Assanto, E., Di Marco, V., & Craxì, A. (n.d.). efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study. Digestive and liver disease, 52, e26–e27. http://access.bl.uk/ark:/81055/vdc_100101587187.0x000017